VRTX
Vertex Pharmaceuticals Inc
Price:  
491.57 
USD
Volume:  
1,691,445.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Vertex Relative Valuation

8.3%
Upside

As of 2024-07-20, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 532.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 491.57 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is 8.3%.

The range of the Relative Valuation is 498.43 - 679.43 USD.

Range Selected
Trailing P/E multiples 32.0x - 43.6x 35.9x
Forward P/E multiples 30.4x - 34.4x 30.7x
Fair Price 498.43 - 679.43 532.20
Upside 1.4% - 38.2% 8.3%
491.57 USD
Stock Price
532.20 USD
Fair Price

Vertex Relative Valuation - Historical P/E Data

Date P/E
2024-07-19 31.56
2024-07-18 31.34
2024-07-17 31.35
2024-07-16 31.39
2024-07-15 31.51
2024-07-12 31.38
2024-07-11 31.60
2024-07-10 31.56
2024-07-09 31.20
2024-07-08 30.94
2024-07-05 30.47
2024-07-03 30.19
2024-07-02 30.42
2024-07-01 30.25
2024-06-28 30.09
2024-06-27 30.34
2024-06-26 30.43
2024-06-25 30.42
2024-06-24 30.49
2024-06-21 30.09
2024-06-20 30.26
2024-06-18 30.00
2024-06-17 30.41
2024-06-14 30.86
2024-06-13 30.75
2024-06-12 30.55
2024-06-11 30.91
2024-06-10 31.03
2024-06-07 31.01
2024-06-06 31.17
2024-06-05 31.01
2024-06-04 30.49
2024-06-03 30.19
2024-05-31 29.23
2024-05-30 28.44
2024-05-29 28.32
2024-05-28 28.69
2024-05-24 29.34
2024-05-23 28.94
2024-05-22 28.73
2024-05-21 28.38
2024-05-20 28.63
2024-05-17 28.58
2024-05-16 28.29
2024-05-15 28.09
2024-05-14 27.52
2024-05-13 27.60
2024-05-10 27.14
2024-05-09 26.90
2024-05-08 26.89